About biologit
biologit is a company based in Dublin (Ireland) founded in 2021 by Bruno Ohana and Nicole Baker.. biologit has raised $1.09 million across 1 funding round from investors including Enterprise Ireland and Ryan Group Holdings. biologit offers products and services including biologit MLM-AI, biologit Database, Pharmacovigilance Services, and Veterinary Pharmacovigilance. biologit operates in a competitive market with competitors including DrugCard, Beijing Dongxie Network, Sentrx, Advera Health and My Meds & Me, among others.
- Headquarter Dublin, Ireland
- Founders Bruno Ohana, Nicole Baker
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$1.09 M (USD)
in 1 rounds
-
Latest Funding Round
$1.09 M (USD), Seed
Apr 10, 2022
-
Investors
Enterprise Ireland
& 1 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of biologit
biologit offers a comprehensive portfolio of products and services, including biologit MLM-AI, biologit Database, Pharmacovigilance Services, and Veterinary Pharmacovigilance. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
AI-powered tool for automated literature screening in safety surveillance.
Hosts global literature sources with automatic de-duplication features.
Expert services for regulatory compliance in pharmacovigilance monitoring.
Monitoring solutions for veterinary safety and regulatory requirements.
Unlock access to complete
Leadership Team
2 people
Software Development Team
2 people
Staff Team
1 people
PV Team
1 people
Co Team
1 people
Unlock access to complete
Funding Insights of biologit
biologit has successfully raised a total of $1.09M through 1 strategic funding round. The most recent funding activity was a Seed round of $1.09 million completed in April 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Seed — $1.1M
-
First Round
First Round
(10 Apr 2022)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr, 2022 | Amount | Seed - biologit | Valuation | Ryan Group Holdings , Enterprise Ireland |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in biologit
biologit has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include Enterprise Ireland and Ryan Group Holdings. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Ryan Group Holdings is engaged in startup investment and support.
|
Founded Year | Domain | Location | |
|
Support is provided to Irish manufacturing and service sector businesses.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by biologit
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - biologit
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Biologit Comparisons
Competitors of biologit
biologit operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as DrugCard, Beijing Dongxie Network, Sentrx, Advera Health and My Meds & Me, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Drug pharmacovigilance solutions are provided for pharmaceutical industries.
|
|
| domain | founded_year | HQ Location |
AI-based pharmacovigilance platform is developed for report analysis and monitoring.
|
|
| domain | founded_year | HQ Location |
Specialized pharmacovigilance software and services are developed and provided.
|
|
| domain | founded_year | HQ Location |
Provider of a SaaS based regulatory data analysis and pharmacovigilance platform for life science industry
|
|
| domain | founded_year | HQ Location |
Adverse events and product quality are captured for life sciences.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about biologit
When was biologit founded?
biologit was founded in 2021 and raised its 1st funding round 1 year after it was founded.
Where is biologit located?
biologit is headquartered in Dublin, Ireland.
Who is the current CEO of biologit?
Nicole Baker is the current CEO of biologit. They have also founded this company.
Is biologit a funded company?
biologit is a funded company, having raised a total of $1.09M across 1 funding round to date. The company's 1st funding round was a Seed of $1.09M, raised on Apr 10, 2022.
What does biologit do?
Biologit was founded in 2021 and is based in Dublin, Ireland. AI-based tools are developed for drug pharmacovigilance within the pharmaceutical sector. Information from scientific abstracts, journals, and literature is collected, monitored, researched, assessed, and evaluated using these AI-assisted solutions. Operations emphasize data handling and analysis to support pharmacovigilance activities across relevant geographies.
Who are the top competitors of biologit?
biologit's top competitors include Sentrx, My Meds & Me and DrugCard.
What products or services does biologit offer?
biologit offers biologit MLM-AI, biologit Database, Pharmacovigilance Services, and Veterinary Pharmacovigilance.
Who are biologit's investors?
biologit has 2 investors. Key investors include Enterprise Ireland, and Ryan Group Holdings.